SLNO
Soleno Therapeutics Inc
$53.01
+0.00%
52W High
$90.32
52W Low
$29.43
Market Cap
$2.76B
Next Earnings Report
Last Reported
May 12, 2026 Missed
Actual: $0.59
vs. Consensus: $0.68
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q1 2026
May 12, 2026
1-Day:
+0.04%
Q1 2026
May 11, 2026
1-Day:
-0.02%
Q1 2026
May 7, 2026
1-Day:
+0.00%
5-Day:
-0.04%
Q1 2026
May 6, 2026
1-Day:
+0.02%
5-Day:
+0.00%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $91.7M | -87.5% | 99.1% | 44.1% | $43.4M |
| Q3'25 | $66.0M | +10,000.0% | 98.3% | 33.5% | $26.0M |
| Q2'25 | $32.7M | +10,000.0% | 97.9% | -20.0% | -$4.7M |
| Q4'23 | $3.4M | +1,114.3% | 85.8% | -403.7% | -$11.3M |
| Q1'18 | $734.9M | +10,000.0% | -11.6% | -0.5% | -$3.8M |
| Q2'17 | $1,000 | -99.7% | -4,100.0% | -10,000.0% | -$4.0M |
| Q1'17 | $265,000 | -40.7% | 21.1% | -834.0% | -$2.9M |
| Q4'16 | $283,788 | +17.5% | 21.7% | -1,041.7% | -$2.6M |
Company Information
Symbol
SLNO
Company
Soleno Therapeutics Inc
Market Cap
$2.76B